CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...